David Russell
Department of Pharmaceuticals
Horizon Discovery
Austria
Biography
David is Professor of Medicine, Division of Hematology and Adjunct Professor of Biochemistry at the University of Washington School of Medicine. He is as a Special Member of the SAB with responsibility for leading Horizon’s future thinking in human gene-targeting. David pioneered the use of adeno-associated virus (AAV) vectors to introduce precise sequence changes at any endogenous chromosomal locus. This approach has revolutionized the speed at which human isogenic cell lines with defined genetic properties can be generated. David is also leading Horizon in developing strategies for the application of AAV technology in the in-vitro stem-cell field. David has published over 60 peer-review publications in the field of gene-targeting and gene therapy, and is on the editorial board of four international peer-reviewed journals.
Research Interest
Biopharmaceutical Industry
